Filter
574
Filtered Results: 574
Text search:
R.
Bruno
Featured
Recommendations
44
New Publications
87
Language
Document type
No document type
247
Studies & Reports
157
Guidelines
105
Manuals
25
Fact sheets
13
Strategic & Response Plan
11
Training Material
8
Brochures
4
Resource Platforms
3
Situation Updates
1
Countries / Regions
Global
44
Germany
15
Latin America and the Carribbean
14
Western and Central Europe
12
India
12
Russia
11
Africa
10
Argentina
8
Brazil
8
Ukraine
7
Asia
7
Congo, Democratic Republic of
7
Sierra Leone
6
Paraguay
6
South Africa
6
Philippines
5
Eastern Europe
5
Mozambique
4
Tanzania
4
Myanmar / Burma
4
Kenya
3
Benin
3
Rwanda
3
Cameroon
3
Syria
3
Senegal
3
Burkina Faso
3
Middle East and North Africa
3
Uganda
3
Tajikistan
2
Nepal
2
Chile
2
West and Central Africa
2
Eastern Europe and Central Asia
2
East and Southern Africa
2
Bolivia
2
Yemen
2
Angola
2
South Sudan
2
Indonesia
2
Somalia
2
Ecuador
2
Thailand
1
Lesotho
1
China
1
Kazakhstan
1
Canada
1
Kyrgyzstan
1
Afghanistan
1
Malawi
1
Zimbabwe
1
Morocco
1
Mongolia
1
Guinea
1
Italy
1
USA
1
Cambodia
1
Guinea-Bissau
1
Venezuela
1
Hungary
1
South–East Asia Region
1
Western Pacific Region
1
Southern Africa
1
Lebanon
1
Vietnam
1
Sudan
1
Ethiopia
1
Poland
1
Chad
1
Liberia
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
132
Clinical Guidelines
49
Public Health
39
Women & Child Health
21
Key Resources
16
Pharmacy & Technologies
6
Capacity Building
4
Toolboxes
Mental Health
95
COVID-19
73
Planetary Health
49
NTDs
33
TB
27
HIV
25
Caregiver
24
Refugee
20
Rapid Response
19
Disability
19
Global Health Education
19
NCDs
16
Pharmacy
14
Health Financing Toolbox
8
AMR
6
Natural Hazards
5
Social Ethics
5
Ebola
4
Conflict
4
Specific Hazards
3
Polio
3
Cholera
2
Zika
1
Après un rappel des données générales sur la malnutrition infantile, nous décrirons l'évolution de la mortalité et de la morbidité de ce fléau. Puis, nous exposerons la méthodologie et les résultats de notre étude. L'étude est d'abord rétrospective, analysant les indicateurs de fonctio...
: interim guidance, 17 February 2021
This document provides interim guidance on the management of the blood supply in response to the pandemic outbreak of coronavirus disease (COVID-19). It emphasizes the importance of being prepared and responding quickly and outlines key actions and measures that...
WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19.
We recommend systemic corticosteroids for the treatment of patients with severe and critical COVID-19. We suggest not to use corticosteroids in the treatment of patients ...
Orientação provisória. 2 de setembro de 2020
Questão clínica: Qual é o papel dos corticosteroides sistêmicos no tratamento de pacientes com COVID-19? Público-alvo: O público-alvo consiste principalmente de médicos, seguido por tomadores de decisão na área de saúde.
interim Guidance 1 December 2020. Updated version
This document provides updated guidance on mask use in health care and community settings, and during home care for COVID-19 cases. It is intended for policy makers, public health and infection prevention and control professionals, health care manag...
Применение масок в условиях COVID-19
recommended
Временные руководящие принципы 1 декабря 2020 года. Обновленная версия
В этом документе представлено обновленное руководство по использованию масок в медицинских ...
: interim guidance, 17 February 2021
This document provides interim guidance on the management of the blood supply in response to the pandemic outbreak of coronavirus disease (COVID-19). It emphasizes the importance of being prepared and responding quickly and outlines key actions and measures that...
Objetivos:
• Brindar lineamientos conceptualessobre la Fasciolosis e Hidatidosis.
• Conocer el ciclo de transmisión de la Fasciolosis e Hidatidosis.
• Describir la epidemiología y vía de transmisión de la fasciolosis e hidatidosis.
• Conocer y aplicar las medidas de prevención y...
The results of the report clearly show that in 2020, a year dominated by the emergence of COVID-19 and its associated health and economic crises, governments around the world rose to the challenge. Sharp increases in government spending on health at all country income levels underpinned the rise in ...
Le secteur de la santé a beaucoup évolué au cours des 20 dernières années. Les innovations technologiques ainsi que notre connaissance des maladies ont contribué à allonger l’espérance de vie au 20ème siècle. Cependant, l’un des plus grands défis
aujourd’hui n’est pas de rester a...
The objectives of the meeting were:
1. To step up the commitment of national authorities and technical and financial partners toWHO’s elimination objective for g-HAT.
2. To share achievements, challenges and views on the elimination goal among countries and implementing partners.
3. To assess t...
Ce rapport inclut des analyses tirées des consultations régionales informelles menées dans la Région africaine, dans les Caraïbes et en Amérique du Nord, dans la Région européenne, dans la Région de la Méditerranée orientale, en Amérique latine ainsi que dans la Région de l’Asie du Su...
El presente informe incluye análisis de consultas informales en cinco de las regiones de la OMS: la Región de África, la Región de las Américas (donde se realizaron consultas separadas para el Caribe y América del Norte, y para América Latina), la Región de Asia Sudoriental, la Región de Eu...
La fièvre jaune est endémique dans plusieurs pays d'Amérique latine. Afin d'aider les décideurs à hiérarchiser les actions de prévention contre cette maladie, l'Organisation panaméricaine de la santé présente ces profils de pays avec une sélection concise et complète de données provenan...
The 2021 Report examines country health spending patterns and trends over the past 20 years, before the COVID-19 pandemic, with greater focus on public spending on health. The report also presents spending on primary health care, preliminary health expenditure in 2020 for a small set of countries (i...
The GFF needs an additional US$2.5 billion from 2021 to 2025 to enable countries to protect health gains and accelerate progress toward the 2030 Goals. Of this amount, the GFF urgently needs to secure new pledges of US$1.2 billion by the end of 2021 to help its current 36 partner countries protect ...
Pathogen genomic surveillance has become a priority for public health systems in recent years. Genomic sequencing is increasingly being used to characterize pathogens and monitor important public health priorities (e.g. poliovirus, influenza virus, Mycobacterium tuberculosis and Vibrio cholerae, ant...
Ce rapport inclut des analyses tirées des consultations régionales informelles menées dans la Région africaine, dans les Caraïbes et en Amérique du Nord, dans la Région européenne, dans la Région de la Méditerranée orientale, en Amérique latine ainsi que dans la Région de l’Asie du Su...
El presente informe incluye análisis de consultas informales en cinco de las regiones de la OMS: la Región de África, la Región de las Américas (donde se realizaron consultas separadas para el Caribe y América del Norte, y para América Latina), la Región de Asia Sudoriental, la Región de Eu...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
